d.nilsen
TL2 · Bari
Contributes reviews on supplier material. Based in Bari.
Joined 15 December 2024 · last posted 2d
71Posts here
1Topics
0Solutions
180Likes received
187Likes given
16Badges
133Days visited
1kPosts read
Recent activity
Full stream-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #71 · Access › Insurance & coverage · 26 Jul 2026 · 0 likes Where I part company with post #67, and it is a narrow parting. The number people quote for Prior authorisation is a central estimate presented without its interval,…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #115 · Analytics › Home & field testing · 23 Jul 2026 · 18 likes That is consistent with mine, for whatever one more account is worth.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 19 Jul 2026 · 22 likes Worth separating two things that post #14 runs together. Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #2 · Compounds › Oral incretins · 16 Jul 2026 · 1 like Timing consistency matters more for oral dosing than for weekly injection, because absorption depends on the state of the stomach and the state of the stomach varies…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #123 · Practice › Reconstitution · 13 Jul 2026 · 4 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #53 · Outcomes › Body composition · 11 Jul 2026 · 6 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. The practical version of ultrasound and skinfolds is three…
-
Common supplements people ask about, assessed one at a time Replied, post #13 · Practice › Interactions · 5 Jul 2026 · 24 likes Adding a reference point for common supplements. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #71 · Sourcing › Red flags · 28 Jun 2026 · 30 likes Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way that allows accountability.
-
Talking to a therapist about this specifically Replied, post #13 · Wellbeing › Mental health · 16 Jun 2026 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #54 · Practice › Administration · 12 Jun 2026 · 30 likes Taking post #53 at face value and following it one step further. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
A pooled estimate that changed when one trial was added Replied, post #6 · Evidence › Meta-analyses · 4 Jun 2026 · 0 likes Reading the pooled figure without reading the inclusion criteria is the equivalent of quoting a trial without its population. Both are common and both are avoidable.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #94 · Compounds › Tirzepatide · 27 May 2026 · 12 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…